协和医学杂志
協和醫學雜誌
협화의학잡지
MEDICAL JOURNAL OF PEKING UNION MEDICAL COLLEGE HOSPITAL
2014年
3期
283-289
,共7页
侯立安%邱玲%邸茜%国秀芝%解宏杰%李鹏昌%王凯%程歆琦%刘荔
侯立安%邱玲%邸茜%國秀芝%解宏傑%李鵬昌%王凱%程歆琦%劉荔
후립안%구령%저천%국수지%해굉걸%리붕창%왕개%정흠기%류려
床旁检验%不精密度%准确度%比对实验
床徬檢驗%不精密度%準確度%比對實驗
상방검험%불정밀도%준학도%비대실험
point-of-care testing%imprecision%accuracy%comparison test
目的:验证CardioChek PA床旁血脂检测仪测定全血总胆固醇( total cholesterol, TC)、甘油三酯( triglycer-ide, TG)和高密度脂蛋白胆固醇(high-density lipoprotein cholesterol, HDL-C)的准确度及其与全自动生化分析仪结果的可比性。方法使用同一批号试纸条分别在3台CardioChek PA血脂检测仪上连续检测低、中、高三个浓度水平全血20次,评价TC、 TG和HDL-C各项目的批内不精密度和仪器间总不精密度;在同一台仪器上使用三个批号的试纸条检测全血各10次,计算批内不精密度和总不精密度。筛选血脂浓度覆盖高、中、低三个水平的54名志愿者,清晨空腹采集末梢全血,在3台床旁血脂仪上测定血脂;同时采集静脉血,在4种不同的全自动生化分析仪检测血清TC、 TG及HDL-C。绘制Bland-Altman图,比较CardioChek PA与各生化分析仪测定结果的离散趋势;将CardioChek PA检测结果与不同生化分析系统及参考方法检测结果进行线性回归;计算CardioChek PA与不同生化分析系统的偏差及百分偏差,同时判定在医学决定水平处偏差是否符合相关要求。结果3台 CardioChek PA 仪器低、中、高水平的总不精密度 TC 分别为:2.69%、4.88%、3.51%, TG分别为5.51%、5.27%、4.96%, HDL-C分别为7.27%、6.84%、6.79%;相同仪器、不同批号试纸间总不精密度TC为4.70%, TG为7.66%, HDL-C为8.61%。 CardioChek PA检测系统与4种全自动生化仪分析比对结果显示: TC与各系统的偏差最小,在-2.21%~2.56%之间, HDL-C在-1.12%~5.57%之间, TG除与BeckmanDxC 800偏差较大外(25.85%),与其他3个系统的平均百分偏差在-4.55%~13.34%之间。医学决定水平偏差分析显示: TC在不同医学决定水平处的偏差在-3.27%~1.96%之间, TG 在-11.05%~13.06%之间, HDL-C 在-5.86%~11.56%之间,均满足美国国家胆固醇教育计划总允许误差标准(15%)。进一步的正确度验证结果显示:与参考方法比对, TC在医学决定水平处偏倚分别为1.96%和0.77%; HDL-C分别为2.34%和4.87%。结论 CardioChek PA床旁血脂检测仪准确度满足临床需求,适用于临床血脂异常筛查及治疗检测。
目的:驗證CardioChek PA床徬血脂檢測儀測定全血總膽固醇( total cholesterol, TC)、甘油三酯( triglycer-ide, TG)和高密度脂蛋白膽固醇(high-density lipoprotein cholesterol, HDL-C)的準確度及其與全自動生化分析儀結果的可比性。方法使用同一批號試紙條分彆在3檯CardioChek PA血脂檢測儀上連續檢測低、中、高三箇濃度水平全血20次,評價TC、 TG和HDL-C各項目的批內不精密度和儀器間總不精密度;在同一檯儀器上使用三箇批號的試紙條檢測全血各10次,計算批內不精密度和總不精密度。篩選血脂濃度覆蓋高、中、低三箇水平的54名誌願者,清晨空腹採集末梢全血,在3檯床徬血脂儀上測定血脂;同時採集靜脈血,在4種不同的全自動生化分析儀檢測血清TC、 TG及HDL-C。繪製Bland-Altman圖,比較CardioChek PA與各生化分析儀測定結果的離散趨勢;將CardioChek PA檢測結果與不同生化分析繫統及參攷方法檢測結果進行線性迴歸;計算CardioChek PA與不同生化分析繫統的偏差及百分偏差,同時判定在醫學決定水平處偏差是否符閤相關要求。結果3檯 CardioChek PA 儀器低、中、高水平的總不精密度 TC 分彆為:2.69%、4.88%、3.51%, TG分彆為5.51%、5.27%、4.96%, HDL-C分彆為7.27%、6.84%、6.79%;相同儀器、不同批號試紙間總不精密度TC為4.70%, TG為7.66%, HDL-C為8.61%。 CardioChek PA檢測繫統與4種全自動生化儀分析比對結果顯示: TC與各繫統的偏差最小,在-2.21%~2.56%之間, HDL-C在-1.12%~5.57%之間, TG除與BeckmanDxC 800偏差較大外(25.85%),與其他3箇繫統的平均百分偏差在-4.55%~13.34%之間。醫學決定水平偏差分析顯示: TC在不同醫學決定水平處的偏差在-3.27%~1.96%之間, TG 在-11.05%~13.06%之間, HDL-C 在-5.86%~11.56%之間,均滿足美國國傢膽固醇教育計劃總允許誤差標準(15%)。進一步的正確度驗證結果顯示:與參攷方法比對, TC在醫學決定水平處偏倚分彆為1.96%和0.77%; HDL-C分彆為2.34%和4.87%。結論 CardioChek PA床徬血脂檢測儀準確度滿足臨床需求,適用于臨床血脂異常篩查及治療檢測。
목적:험증CardioChek PA상방혈지검측의측정전혈총담고순( total cholesterol, TC)、감유삼지( triglycer-ide, TG)화고밀도지단백담고순(high-density lipoprotein cholesterol, HDL-C)적준학도급기여전자동생화분석의결과적가비성。방법사용동일비호시지조분별재3태CardioChek PA혈지검측의상련속검측저、중、고삼개농도수평전혈20차,평개TC、 TG화HDL-C각항목적비내불정밀도화의기간총불정밀도;재동일태의기상사용삼개비호적시지조검측전혈각10차,계산비내불정밀도화총불정밀도。사선혈지농도복개고、중、저삼개수평적54명지원자,청신공복채집말소전혈,재3태상방혈지의상측정혈지;동시채집정맥혈,재4충불동적전자동생화분석의검측혈청TC、 TG급HDL-C。회제Bland-Altman도,비교CardioChek PA여각생화분석의측정결과적리산추세;장CardioChek PA검측결과여불동생화분석계통급삼고방법검측결과진행선성회귀;계산CardioChek PA여불동생화분석계통적편차급백분편차,동시판정재의학결정수평처편차시부부합상관요구。결과3태 CardioChek PA 의기저、중、고수평적총불정밀도 TC 분별위:2.69%、4.88%、3.51%, TG분별위5.51%、5.27%、4.96%, HDL-C분별위7.27%、6.84%、6.79%;상동의기、불동비호시지간총불정밀도TC위4.70%, TG위7.66%, HDL-C위8.61%。 CardioChek PA검측계통여4충전자동생화의분석비대결과현시: TC여각계통적편차최소,재-2.21%~2.56%지간, HDL-C재-1.12%~5.57%지간, TG제여BeckmanDxC 800편차교대외(25.85%),여기타3개계통적평균백분편차재-4.55%~13.34%지간。의학결정수평편차분석현시: TC재불동의학결정수평처적편차재-3.27%~1.96%지간, TG 재-11.05%~13.06%지간, HDL-C 재-5.86%~11.56%지간,균만족미국국가담고순교육계화총윤허오차표준(15%)。진일보적정학도험증결과현시:여삼고방법비대, TC재의학결정수평처편의분별위1.96%화0.77%; HDL-C분별위2.34%화4.87%。결론 CardioChek PA상방혈지검측의준학도만족림상수구,괄용우림상혈지이상사사급치료검측。
Objective To validate the accuracy of CardioChek PA lipid point-of-care devices in determi-ning total cholesterol ( TC ) , triglyceride ( TG ) , and high-density lipoprotein cholesterol ( HDL-C ) in whole blood and the comparability with results determined by full-automatic biochemical analyzer .Methods We deter-mined the low, medium, and high levels of TG, TC, and HDL-C in whole blood with single reagent lot number 20 times using 3 different CardioChek PA devices to evaluate inter-run and devices'coefficient of variations ( CVs) , and used single CardioChek PA device with 3 reagent lot number to determine the whole blood 10 times for evaluating inter-run and total CVs .Fifty-four volunteers whose lipid profiles covered up high , medium, and low levels were recruited .Lipids in fasting periphery whole blood and venous serum were collected and deter -mined using 3 different CardioChek PA devices and 4 kinds of full-automatic biochemical analyzers , respectively . Bland-Altman plot was made to analyze the comparability of results from CardioChek PA and the full -automatic bi-ochemical analyzers .Linear regression was analyzed using results of CardioChek PA and full -automatic biochemi-cal analyzers .Bias and percentage bias were determined between CardioChek PA and different automatic bio -chemical analyzers; meanwhile, whether they satisfied the requirements of medical decision levels was deter -mined.Results The total CVs of TC in low , medium, and high levels in 3 different devices were 2.69%, 4.88%, and 3.51%, respectively;for TG, they were 5.51%, 5.27%and 4.96%;and for HDL-C, they were 7.27%, 6.84%and 6.79%.The total CVs of TC , TG, and HDL-C determined with the same device but dif-ferent reagent lot number were 4.70%, 7.66%, and 8.61%, respectively .Comparison of the results from Car-dioChek PA devices and the 4 kinds of full-automatic biochemical analyzers showed lowest deviation for TC with-2.21% 2.56%, and for HDL-C with -1.12% 5.57%;the deviation of TG results of BeckmanDxC 800 was relatively high with 25.85%, but in other 3 systems were -4.55% 13.34%.Deviation of TC , TG, and HDL-C in different medical decision levels were -3.27% 1.96%, -11.05% 13.06%, and -5.86% 11.56%, respectively , all of which could satisfy the requirements of the National Cholesterol Education Program ( NCEP) . Compared with reference methods , the biases of TC in medical decision levels were 1.96% and 0.77%; for HDL-C, they were 2.34%and 4.87%.Conclusion The accuracy of CardioChek PA lipid point-of-care device can satisfy the clinical requirements , and the device can be used in the screening and monitoring of dyslipidemia .